Author Correction: PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma. - Yokoyama D; Hisamori S; Deguchi Y; Nishigori T; Okabe H; Kanaya S; Manaka D; Kadokawa Y; Hata H; Minamiguchi S; Tsunoda S; Obama K; et al. (Scientific reports, 2021)